Elicio Therapeutics, Inc. · NASDAQ:ELTX
Elicio Therapeutics, Inc. shareholders
As of Jun 30, 2026, 45 institutions reported holding Elicio Therapeutics, Inc., 14.9% of its shares. Largest: Knoll Capital Management, LLC, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Elicio Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Knoll Capital Management, LLC | 1.21M | 4.6% | +581K | Aug 14, 2026 |
| BlackRock | 766K | 2.9% | +715K | Aug 7, 2026 |
| Vanguard | 754K | 2.9% | +161K | Aug 13, 2026 |
| Geode Capital | 311K | 1.2% | +176K | Aug 12, 2026 |
| State Street | 179K | 0.68% | +129K | Aug 7, 2026 |
| Northern Trust | 130K | 0.50% | +70,428 | Aug 13, 2026 |
| Ikarian Capital, LLC | 100K | 0.38% | new | Aug 14, 2026 |
| AllianceBernstein | 81,280 | 0.31% | new | Aug 14, 2026 |
| UBS | 40,419 | 0.15% | +6,650 | Aug 13, 2026 |
| Schwab | 31,706 | 0.12% | new | Aug 14, 2026 |